Sanofi logo

Sanofi dividend yield (ttm)NASDAQ: SNY

Annual

Dividend yield (TTM)

3.88%
+0.03%+0.78%

8 min ago

-46.48%vs 3 years high
+618.52%vs 3 years low
77.78%vs. sector
Performance
Most recent+0.8%
1 year+6.9%
3 years+0.5%
5 years+3.5%

Add series to chart

(max: 6)
company, ETF, index, featured screener or watchlist
series name

Suggested series

Dividend yield (TTM) performance

Most recent change
SNY+0.8%
BSX-
SYK-1.1%
VRTX-
MDT+1.0%
GILD-2.0%
BMY+0.7%
1 year change
SNY+6.9%
BSX-
SYK-22.1%
VRTX-
MDT-20.2%
GILD-9.4%
BMY+12.1%
3 years change
SNY+0.5%
BSX-
SYK-3.3%
VRTX-
MDT+54.3%
GILD-17.5%
BMY+33.8%
5 years change
SNY+3.5%
BSX-
SYK-10.2%
VRTX-
MDT+53.5%
GILD-7.5%
BMY+50.7%

Dividend yield (TTM) performance

SNYBSXSYKVRTXMDTGILDBMY
Most recent+0.8%--1.1%-+1.0%-2.0%+0.7%
1 year+6.9%--22.1%--20.2%-9.4%+12.1%
3 years+0.5%--3.3%-+54.3%-17.5%+33.8%
5 years+3.5%--10.2%-+53.5%-7.5%+50.7%
FAQ

What is Sanofi dividend yield (ttm)?

Sanofi dividend yield (ttm) is 3.88%

What is Sanofi dividend yield (ttm) compared to its 3-years maximum value?

Sanofi dividend yield (ttm) is 53.52% of its 3-years maximum value

What is Sanofi dividend yield (ttm) compared to other companies from its sector (Healthcare)?

Sanofi dividend yield (ttm) is higher than 77.78% of the companies in the same sector (Healthcare)

How has Sanofi dividend yield (ttm) changed over the year?

Over the past year, Sanofi dividend yield (ttm) has increased by 6.9%. During the same period, , Stryker has decreased by 22.1%, Medtronic has dropped by 20.2%, Gilead Sciences has decreased by 9.4%, Bristol-Myers Squibb has grown by 12.1%

How has Sanofi dividend yield (ttm) changed over the 3 years?

During the last 3 years, Sanofi dividend yield (ttm) has increased by 0.5%. Over the same period, , Stryker has decreased by 3.3%, Medtronic has increased by 54.3%, Gilead Sciences has decreased by 17.5%, Bristol-Myers Squibb has grown by 33.8%

How has Sanofi dividend yield (ttm) changed over the 5 years?

For the past 5 years, Sanofi dividend yield (ttm) has increased by 3.5%. In the same period, , Stryker has decreased by 10.2%, Medtronic has increased by 53.5%, Gilead Sciences has decreased by 7.5%, Bristol-Myers Squibb has grown by 50.7%